Auspex Pharmaceuticals Secures $12,000,000 New Funding Round

  • Feed Type
  • Date
    7/20/2010
  • Company Name
    Auspex Pharmaceuticals
  • Mailing Address
    1261 Liberty Way Vista, CA 92081-8356
  • Company Description
    Auspex Pharmaceuticals is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs. For more than five years the company has worked to apply its targeted deuteration strategy to drug molecules across multiple therapeutic areas, secure a proprietary position on several hundred compounds and initiate development on multiple clinical candidates.
  • Website
    http://www.auspexpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.